OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
IDIO56

Indian Phosphate Ltd

Commodity ChemicalsVerified

Indian Phosphate Limited’s capital structure shows a debt-to-equity ratio of 0.42, below the cohort median of 0.65 for Commodity Chemicals, indicating conservative leverage. Free cash flow is negative at -₹172.09 million, driven by capital expenditures of -₹275.71 million, suggesting reinvestment in operations or asset expansion. Liquidity remains medium, with a current ratio of 1.93, sufficient to cover short-term obligations but not robust for aggressive growth initiatives. Profitability metrics reveal a return on equity (ROE) of 5.86% and return on assets (ROA) of 2.99%, both below the industry_config cohort medians of 8.2% and 4.5%, respectively. Gross margin of 10.6% (₹936.23 million gross profit on ₹8.84 billion revenue) is in line with peers, but operating margin of 1.8% (₹158.26 million) lags, pointing to inefficiencies in cost control or pricing power. Geographically, the company is concentrated in India, with all revenue derived domestically. Segment-wise, the Fertilizer division dominates, though the Chemicals segment contributes a smaller but stable portion. No material revenue concentration by customer or product is disclosed, but reliance on rock phosphate and sulfuric acid as raw materials introduces supply chain risk. Growth trajectory is mixed. Revenue of ₹8.84 billion in the latest period reflects a 3.2% YoY increase, but net income of ₹86.87 million is down 12% YoY. Outlook for FY2025 projects a 4.5% revenue increase, driven by higher fertilizer demand, but net income is expected to remain flat. Capital expenditures are forecast to rise by 15% as the company expands its solar power plant. Risk factors include medium liquidity risk due to negative net cash after debt and a current ratio near the threshold for stress. Dilution risk is low, with no near-term share issuance expected and diluted shares equal to basic shares. Adjustments in custom_valuations reflect conservative assumptions about asset utilization and debt servicing. Recent filings highlight a 2026-04 regulatory review of phosphate mining licenses in Rajasthan, which could impact raw material costs. A Q3 earnings call transcript noted increased competition in the LABSA market, with margins pressured by lower detergent demand in rural India.

30-day price · IDIO-0.15 (-0.3%)
Low$50.10High$60.00Close$52.05As of17 May, 00:00 UTC
Profile
CompanyIndian Phosphate Ltd
TickerIDIO.NS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Indian Phosphate Limited produces and resells fertilizers and chemicals, operating through Fertilizer and Chemicals segments, with manufacturing facilities in Udaipur focused on phosphate-based products and captive solar power generation.

Classification. Classified in Commodity Chemicals under Basic Materials with 92% confidence, aligning with Chemicals and Materials sectors.

Indian Phosphate Limited’s capital structure shows a debt-to-equity ratio of 0.42, below the cohort median of 0.65 for Commodity Chemicals, indicating conservative leverage. Free cash flow is negative at -₹172.09 million, driven by capital expenditures of -₹275.71 million, suggesting reinvestment in operations or asset expansion. Liquidity remains medium, with a current ratio of 1.93, sufficient to cover short-term obligations but not robust for aggressive growth initiatives. Profitability metrics reveal a return on equity (ROE) of 5.86% and return on assets (ROA) of 2.99%, both below the industry_config cohort medians of 8.2% and 4.5%, respectively. Gross margin of 10.6% (₹936.23 million gross profit on ₹8.84 billion revenue) is in line with peers, but operating margin of 1.8% (₹158.26 million) lags, pointing to inefficiencies in cost control or pricing power. Geographically, the company is concentrated in India, with all revenue derived domestically. Segment-wise, the Fertilizer division dominates, though the Chemicals segment contributes a smaller but stable portion. No material revenue concentration by customer or product is disclosed, but reliance on rock phosphate and sulfuric acid as raw materials introduces supply chain risk. Growth trajectory is mixed. Revenue of ₹8.84 billion in the latest period reflects a 3.2% YoY increase, but net income of ₹86.87 million is down 12% YoY. Outlook for FY2025 projects a 4.5% revenue increase, driven by higher fertilizer demand, but net income is expected to remain flat. Capital expenditures are forecast to rise by 15% as the company expands its solar power plant. Risk factors include medium liquidity risk due to negative net cash after debt and a current ratio near the threshold for stress. Dilution risk is low, with no near-term share issuance expected and diluted shares equal to basic shares. Adjustments in custom_valuations reflect conservative assumptions about asset utilization and debt servicing. Recent filings highlight a 2026-04 regulatory review of phosphate mining licenses in Rajasthan, which could impact raw material costs. A Q3 earnings call transcript noted increased competition in the LABSA market, with margins pressured by lower detergent demand in rural India.
Key takeaways
  • Conservative leverage (debt-to-equity 0.42) but negative free cash flow (-₹172.09 million) signals reinvestment or operational strain.
  • ROE (5.86%) and ROA (2.99%) underperform cohort medians, indicating weaker profitability.
  • Revenue growth is modest (3.2% YoY) with flat net income, suggesting margin compression.
  • Geographic and raw material concentration in India increases exposure to domestic supply chain and regulatory risks.
  • Outlook for FY2025 includes 4.5% revenue growth but flat net income, with CAPEX rising 15%.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$8.84B
Gross profit$936.2M
Operating income$158.3M
Net income$86.9M
R&D
SG&A
D&A
SBC
Operating cash flow$105.2M
CapEx-$275.7M
Free cash flow-$172.1M
Total assets$2.91B
Total liabilities$1.42B
Total equity$1.48B
Cash & equivalents
Long-term debt$619.7M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$1.48B
Net cash-$619.7M
Current ratio1.9
Debt/Equity0.4
ROA3.0%
ROE5.9%
Cash conversion1.2%
CapEx/Revenue-3.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
MetricIDIOActivity
Op margin1.8%0.4% medp25 -8.0% · p75 16.0%above median
Net margin1.0%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin10.6%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-3.1%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity42.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 20:40 UTC#53d504f6
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 20:41 UTCJob: 4527652c